Ads
-
Related paper
- Fibroblast Growth Factor (FGF) Receptor Mutations: A Pathway to Understanding Multigenic Risk in Disease?
- Caffeic Acid Inhibited Receptor Activator of Nuclear Factor kappaB Ligand (RANKL)-Tumor Necrosis Factor (TNF) alpha-TNF Receptor Associated Factor (TRAF) 6 Induced Osteoclastogenesis Pathway
- Alcoholism, Fibroblast Growth Factor 23 and Cardiovascular Risk
- Modern vector in treatment of patients with lung cancer: tyrosine kinase inhibitors in epidermal growth factor receptor mutations (literature review)
- CLINICAL AND BIOCHEMICAL STUDY OF FIBROBLAST GROWTH FACTOR 23 IN CHRONIC KIDNEY DISEASE
- Fibroblast growth factor 23 and lipid metabolism association in chronic kidney disease
- Relationship between fibroblast growth factor and arrhythmogenesis in normotensive patients with polycystic kidney disease
- FIBROBLAST GROWTH FACTOR 23 AS EARLY MARKER OF MINERAL AND BONE DISORDER IN PATIENTS WITH CHRONIC KIDNEY DISEASE
- Study of Estrogen Receptor, Progesterone Receptor and Human Epidermal Growth Factor Receptor Expression by Immunohistochemistry in Breast Carcinoma
- Expresion of Basic Fibroblast Growth Factor (bFGF) and Cell Apoptosis in Human Pterygium Fibroblast (HPF) after the Adminstration of Epigallocathecin-3-Gallate (EGCG) and Mitomycin-C (In Vitro Laboratory Experimental Study)